Although P2Y6 receptors play different roles in GC and pancreatic cancer, our findings suggest that the P2Y6 receptor-mediated novel downstream pathways might be potential targets for innovative GC prevention/therapy. The gene discussed is P2RY6; the disease is gastric cancer.